Johnson & Johnson’s COVID-19 vaccine, a single-shot alternative to other pharmaceutical companies’ two-dose series, is “no longer available” in the United States, health officials said. The last of the government’s J&J vaccine stock expired May 7, according to the Centers for Disease Control and Prevention. “Dispose of any remaining Janssen COVID-19 Vaccine in accordance with local, state, and federal regulations,” the CDC says on its website. About 19 million Americans received the J&J vaccine, according to CDC statistics. That’s far less than the nearly 367 million Americans who received Pfi...
Report typos and corrections to corrections@rawstory.com.
For customer support contact support@rawstory.com.
